#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fusarium infection Neuromyelitis optica spectrum disorder Philadelphia positive chronic myeloid leukaemia Hereditary spastic paraplegia Activated PI3 kinase delta syndrome Sickle cell anaemia Dilated cardiomyopathy Cholangiosarcoma C3 glomerulopathy Hypochromic anaemia Anti-myelin-associated glycoprotein associated polyneuropathy Tuberous sclerosis complex Leukodystrophy Acute respiratory distress syndrome Niemann-Pick disease More trials…

    Learn about Rare Diseases

    Paroxysmal nocturnal haemoglobinuria – Basic Information Nodal marginal zone B-cell lymphoma – Diagnostics Retinitis pigmentosa – Treatment Adrenogenital syndrome – Diagnostics Hereditary neuropathic amyloidosis – Diagnostics Factor IX deficiency – Treatment Phenylketonuria – Treatment Ewing’s sarcoma metastatic – Trials in Disease Crigler-Najjar syndrome – Life with Disease Short-bowel syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clarithromycin GRAPHITE CARBACHOL Atenolol Mdna11 Sufentanil Citrate LUNRESERTIB Esomeprazole Dulaglutide STREPTOCOCCUS PYOGENES Fluticasone Solrikitug Ht-29-A Rifamycin Sodium Balcinrenone GUAIACOL Cetrimide Lithium Sulphate, Anhydrous HUMAN THROMBIN D5-Ethyl-Beta-D-Glucuronide More therapies…

    Learn about Your Condition

    Hydrocele Endometrial cancer recurrent Thymoma Stem cell transplant Malignant melanoma of eyelid Intervertebral disc protrusion Large cell lung cancer stage 0 HER2 positive breast cancer Hand dermatitis Inner ear disorder Fatty acid oxidation disorder Fibromyalgia Genital herpes simplex Small cell carcinoma Supraventricular tachycardia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing Ciprofloxacin, Colistimethate Sodium, and Ceftazidime for Treating Early Airway Infection in Adults with Bronchiectasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Colistimethate Sodium
    • Ceftazidime Pentahydrate
    • Ciprofloxacin
    France

  • Study on the Effectiveness and Safety of KarXT for Treating Psychosis in Patients with Alzheimer’s Disease

    Recruiting

    3 1
    Belgium Greece Hungary Poland

  • Study on the Effects of Ketamine on Therapy Intensity and Brain Pressure in Patients with Traumatic Brain Injury

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ketamine
    Belgium

  • Study on the Use of Ursodeoxycholic Acid for Patients Undergoing Surgery for Retinal Detachment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rhegmatogenous retinal detachment
    Investigated Drugs:
    • Ursodeoxycholic Acid
    France

  • Study on the Effectiveness and Safety of Dupilumab for Adults with Chronic Itch of Unknown Cause

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pruritus
    Investigated Drugs:
    • Dupilumab
    • Fexofenadine
    • Loratadine
    France Germany Hungary Italy Poland Spain

  • Study Comparing Survival in Patients with Advanced or Metastatic Gastric Cancer Treated with Botensilimab and Balstilimab vs. Standard Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Balstilimab
    • Botensilimab
    • Capecitabine
    France
Previous Page
1 … 440 441 442 443 444 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!